How JNJ's Pharmaceuticals Segment Performed in 1Q17

The neuroscience franchise includes drugs Invega Sustenna, Concerta, and Xeplion. The franchise reported a 3.4% fall in its 1Q17 revenue to ~$1.5 …

Link to Full Article

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!